iSpecimen (ISPC) Current Deferred Revenue (2020 - 2026)
iSpecimen (ISPC) posted quarterly Current Deferred Revenue of $189735.0 for Q1 2026, down 29.78% year-over-year from $270208.0 in Q1 2025, and down 1.45% on a QoQ basis from $192535.0 in Q4 2025.
iSpecimen (ISPC) Current Deferred Revenue (2020 - 2026) Analysis & Trends
iSpecimen (ISPC) has reported Current Deferred Revenue for 7 consecutive years, with $189735.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 29.78% year-over-year to $189735.0; the TTM figure through Mar 2026 stood at $189735.0 (down 29.78% YoY), while the FY2025 annual figure was $192535.0, down 46.62% from the prior year.
- Current Deferred Revenue came in at $189735.0 for Q1 2026 at iSpecimen, down from $192535.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $567321.0 in Q1 2022, with the low at $46910.0 in Q3 2023.
- Average Current Deferred Revenue over 5 years is $239528.4, with a median of $225703.5 recorded in 2024.
- Across the five-year window, Current Deferred Revenue sank 82.79% in 2023 and jumped 504.5% in 2024, its largest moves.
- Year by year, Current Deferred Revenue stood at $132335.0 in 2022, then surged by 214.18% to $415771.0 in 2023, then slipped by 13.24% to $360708.0 in 2024, then slumped by 46.62% to $192535.0 in 2025, then declined by 1.45% to $189735.0 in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $189735.0, $192535.0, and $155506.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | iSpecimen | 931,959.22 | -1.89 Mn | -1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 189,735.00 |
| Dec 31, 2025 | 192,535.00 |
| Sep 30, 2025 | 155,506.00 |
| Jun 30, 2025 | 164,066.00 |
| Mar 31, 2025 | 270,208.00 |
| Dec 31, 2024 | 360,708.00 |
| Sep 30, 2024 | 283,571.00 |
| Jun 30, 2024 | 258,872.00 |
| Mar 31, 2024 | 272,681.00 |
| Dec 31, 2023 | 415,771.00 |
| Sep 30, 2023 | 46,910.00 |
| Jun 30, 2023 | 89,601.00 |
| Mar 31, 2023 | 97,655.00 |
| Dec 31, 2022 | 132,335.00 |
| Jun 30, 2022 | 334,980.00 |
| Mar 31, 2022 | 567,321.00 |
| Dec 31, 2021 | 654,746.00 |
| Sep 30, 2021 | 718,723.00 |
| Jun 30, 2021 | 802,860.00 |
| Dec 31, 2020 | 873,254.00 |